Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Diagnos Inc DGNOF


Primary Symbol: V.ADK

Healthcare Medical Devices
DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time... see more

Recent & Breaking News (TSXV:ADK)

DIAGNOS Announces a Multi-Year Contract with Juarez Health & Medical Tourism Cluster

GlobeNewswire September 16, 2021

DIAGNOS Announces a 3-Year Contract with Cielo Vista Eye Clinic in Mexico

GlobeNewswire September 14, 2021

DIAGNOS Announces Voting Results of Annual Meeting of Shareholders

GlobeNewswire September 10, 2021

DIAGNOS (TSXV:ADK) renews contract with Optina Diagnostics

John Ballem  September 2, 2021

DIAGNOS Announces a Three-Year Contract Renewal with Optina Diagnostics Providing a Telemedicine Platform to Support their Early Detection of Alzheimer's Disease Test

GlobeNewswire September 2, 2021

DIAGNOS Announces Date of Annual General and Special Meeting of Shareholders

GlobeNewswire August 17, 2021

DIAGNOS (TSXV:ADK) signs MoU with Essilor International

John Ballem  August 16, 2021

DIAGNOS signs Memorandum of Understanding with Essilor International.

GlobeNewswire August 16, 2021

DIAGNOS (TSXV:ADK) begins a pilot with Opticalia in Spain

Brieanna McCutcheon  July 28, 2021

DIAGNOS Announces a Pilot with Opticalia in Spain

GlobeNewswire July 28, 2021

DIAGNOS Announces the Official Opening of the AI Assisted Screening Clinic at Magrabi Hospital with the Presence of the Undersecretary of the Ministry of Health of Saudi Arabia

GlobeNewswire July 22, 2021

DIAGNOS (TSXV:ADK) begins clinical trial for the detection and prevention of stroke using its new application CARA-STROKE

John Ballem  July 20, 2021

DIAGNOS initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA-STROKE

GlobeNewswire July 20, 2021

DIAGNOS Announces a Pilot with Hospital Oftalmológico Buena Vista Sinaloa

GlobeNewswire June 15, 2021

IIROC Trading Resumption - ADK

Canada NewsWire June 9, 2021

IRIS, a New Look Vision Group Inc. company, teams up with DIAGNOS in a multi-year agreement to implement Artificial Intelligence technology with support from the INVEST-AI Program

GlobeNewswire June 9, 2021

IIROC Trading Halt - ADK

Canada NewsWire June 4, 2021

DIAGNOS (TSXV:ADK) enters exclusive distribution agreement to reach European markets

Jocelyn Aspa April 6, 2021

DIAGNOS Enters into an Exclusive Distribution Agreement to Access Massive Global Healthcare Market in DACH Countries and Central Europe of Over 140 Million People

GlobeNewswire April 6, 2021

DIAGNOS (TSXV:ADK) finalizing CARA-STROKE application

John Ballem  March 9, 2021